Analysis of the effect of the HLA-B,C-specific mAb B1.23.2 on the metabolic profile of FO-1neo and FO-1β2 melanoma cells showed that this mAb does not modify level of expression of several metabolic markers in FO-1neo cells, but significantly reduces GLUT3 and LDHA expression (Figure 3E), and lactate production in FO-1β2 melanoma cells (Figure 3F). Here, LDHA is linked to melanoma.